Hemolytic Anemia

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Genentech Issues Dear Healthcare Provider Letter Regarding A 2nd Case Of PML In A Raptiva Patient

Published November 27, 2008, 3:13 am, Medical News Today

Genentech, Inc. (NYSE: DNA) announced that the company has issued a Dear Healthcare Provider letter to inform dermatologists and neurologists of a 2nd case of progressive multifocal leukoencephalopathy (PML) which resulted in the death of a 73-year old woman who had received Raptiva® (efalizumab) for approximately four years for treatment of chronic plaque psoriasis.

Discover News | Full Story


Blood donor clinic for your pets (Thursday, November 27, 2008)

Published November 26, 2008, 8:30 am, Wheat City Journal

Donating blood has always been considered a worthwhile cause. Someone out there who is in dire need of your blood type will benefit greatly. You’re helping save someone’s life. For a pet, it’s no

Discover News | Full Story


Tarceva® (erlotinib) Endorsed by the U.K.’s National Institute for Health and Clinical Excellence for Use in Patients ...

Published November 26, 2008, 5:01 am, Centre Daily Times

OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) welcomes today’s announcement by the U.K.’s National Institute for Health and Clinical Excellence (NICE) issuing Final Guidance recommending funding by the National Health Service (NHS) for Tarceva ® (erlotinib) as an alternative treatment to the IV chemotherapy agent docetaxel for the second-line treatment of advanced non-small cell lung cancer (NSCLC). ...

Discover News | Full Story


Tarceva® (erlotinib) Endorsed by the U.K.s National Institute for Health and Clinical Excellence for Use in Patients ...

Published November 26, 2008, 4:38 am, Business Wire via Yahoo! Finance

MELVILLE, N.Y.----OSI Pharmaceuticals, Inc. welcomes today’s announcement by the U.K.’s National Institute for Health and Clinical Excellence issuing Final Guidance recommending funding by the National Health Service for Tarceva® as an alternative treatment to the IV chemotherapy agent docetaxel for the second-line treatment of advanced non-small cell lung cancer .

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a